Haleon plc ( HLN) - Key Metrics
HLN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | ? | ? | ? | ? |
| 2025Q2 | $0.30 | $0.04 | $0.06 | $0.05 |
| 2025Q1 | $0.30 | $0.04 | $0.06 | $0.05 |
| 2024Q4 | $0.30 | $0.03 | ? | ? |
| 2024Q3 | $0.30 | $0.05 | ? | ? |
HLN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | ? |
| 2025Q2 | 51.49% | 21.03 |
| 2025Q1 | 51.49% | 21.98 |
| 2024Q4 | ? | 37.28 |
| 2024Q3 | 37.62% | 18.48 |
HLN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q4 | 3.76% | ? |
| 2025Q2 | 3.02% | 0.61% |
| 2025Q1 | 1.31% | 0.59% |
| 2024Q4 | ? | ? |
| 2024Q3 | ? | 0.51% |
HLN
Price: $9.85
Dividend Yield: 1.97%
Forward Dividend Yield: 2.65%
Payout Ratio: 33.17%
Dividend Per Share: 0.26 USD
Earnings Per Share: 0.50 USD
P/E Ratio: 18.34
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United Kingdom
Volume: 23.3 million
Market Capitalization: 43.3 billion
Average Dividend Frequency: 2
Years Paying Dividends: 4